Bayesian phase I/II adaptively randomized oncology trials with combined drugs (Q641145)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian phase I/II adaptively randomized oncology trials with combined drugs |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Bayesian phase I/II adaptively randomized oncology trials with combined drugs |
scientific article |
Statements
Bayesian phase I/II adaptively randomized oncology trials with combined drugs (English)
0 references
21 October 2011
0 references
adaptive randomization
0 references
dose finding
0 references
drug combination
0 references
0 references
0 references
0.9328241
0 references
0.92158306
0 references
0.9163625
0 references
0.9161676
0 references
0.90263635
0 references
0.90185905
0 references
0.89691764
0 references
